Hennion & Walsh Asset Management Inc. raised its position in BioXcel Therapeutics, Inc. (NASDAQ:BTAI – Get Rating) by 14.5% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 39,185 shares of the company’s stock after acquiring an additional 4,954 shares during the period. Hennion & Walsh Asset Management Inc.’s holdings in BioXcel Therapeutics were […]